e-learning
resources
Virtual 2021
05.09.2021
Burden and epidemiology of COVID-19
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
N. Faria (Porto, Portugal), M. Costa (Porto, Portugal), J. Gomes (Porto, Portugal), M. Sucena (Porto, Portugal)
Source:
Virtual Congress 2021 – Burden and epidemiology of COVID-19
Session:
Burden and epidemiology of COVID-19
Session type:
E-poster
Number:
921
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Faria (Porto, Portugal), M. Costa (Porto, Portugal), J. Gomes (Porto, Portugal), M. Sucena (Porto, Portugal). Alpha-1 antitrypsin deficiency severity and the risk of COVID-19. 921
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Alpha-1 antitrypsin deficiency – a potentially fatal disease
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
Year: 2020
Monitoring disease progression in severe Alpha1 antitrypsin deficiency
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 384s
Year: 2003
Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Alpha-1 antitrypsin deficiency and spontaneous pneumothorax: just a coincidence?
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Year: 2017
Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold
Source: Eur Respir J, 59 (2) 2101410; 10.1183/13993003.01410-2021
Year: 2022
Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe
Source: Eur Respir J 2005; 26: Suppl. 49, 219s
Year: 2005
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept